Dr. Paulo Lizano is a neuropsychiatrist, physician-scientist, and Assistant Professor in Psychiatry at Harvard Medical School with expertise in translational neuroscience. He is the Division Chief of Translational Neuroscience and directs the ASPIRE first episode psychosis clinic at Beth Israel Deaconess Medical Center. 

His research laboratory focuses on understanding the inflammatory and microvascular basis of psychosis, as well as vision science and neuromodulation. Dr. Lizano is particularly interested in the use of complementary translational approaches to study inflammation and microvascular features from different perspectives.

He combines retinal and brain imaging techniques to identify novel biomarkers and examine factors contributing to the cellular-molecular deficits in psychosis by examining patient-specific cellular models of microvascular function. A long-term goal of the laboratory is to identify both diagnostic/prognostic biomarkers and novel tractable treatment targets for patients living with psychosis, particularly those in the early psychosis period.